-
Fadrozole (INNTooltip
International Nonproprietary Name), sold
under the
brand name
Afema (by Novartis), is a selective,
nonsteroidal aromatase inhibitor...
-
fabesetron (INN)
Fabhalta Factive Factrel fadolmidine hydrochloride (USAN)
fadrozole (INN)
falecalcitriol (INN)
falimarev (USAN)
falintolol (INN) falipamil...
-
Anastrozole is
structurally related to letrozole,
fadrozole, and vorozole, with all
being classified as azoles.
Anastrozole was patented...
-
Exemestane (Aromasin)
Vorozole (R-76713; Rivizor)
Formestane (Lentaron)
Fadrozole (Afema) 1,4,6-Androstatrien-3,17-dione (ATD) 4-Androstene-3,6,17-trione...
-
identified CYP27A1 inhibitors,
including the
marketed drugs anastrozole,
fadrozole, bicalutamide, dexmedetomidine, ravuconazole, and posaconazole, have been...
- estrone. The first- and second-generation of NSAIs,
aminoglutethimide and
fadrozole also have a
reducing effect on the
production of
aldosterone and cortisol...
-
including pharmaceuticals.
Benzonitrile is a
precursor in the
synthesis of
Fadrozole, an
aromatase inhibitor used in the
treatment of
breast cancer....
-
inhibitors First-generation:
Aminoglutethimide Testolactone Second-generation:
Fadrozole Formestane Third-generation:
Anastrozole Exemestane Letrozole Antigonadotropins...
-
treatment of osteoporosis.
Antineoplastic agents: Imidazo[1,5-a]pyridines:
Fadrozole (brand name Afema)—an
aromatase inhibitor. Imidazo[4,5-c]pyridines: 3-Deazaneplanocin...
- 1x/2 w****s i.m. 500 mg 1x/2 w****s i.m. 500 mg 1x/1 w**** i.m. 84.8% 91.9% 92.5%
Fadrozole 1 mg 1x/day p.o. 2 mg 2x/day p.o. 82.4% 92.6% Type II ?
Third Exemestane...
